Evidence map›Paper›PMID 35116046›Full record

ArticleFrontiers in immunology2022

Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.

Yasuaki Hirooka, Saki Okuda, Masafumi Sugiyama, Toshihiko Shiga, Yuji Nozaki, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. LncRNAEpigenetics · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yasuaki HirookaDepartment of Rheumatology, Kindai University Nara Hospital, Nara, Japan.
Saki OkudaDepartment of Rheumatology, Kindai University Nara Hospital, Nara, Japan.
Masafumi SugiyamaDepartment of Rheumatology, Kindai University Nara Hospital, Nara, Japan.
Toshihiko ShigaDepartment of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
Yuji NozakiDepartment of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
Koji KinoshitaDepartment of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
Masanori FunauchiDepartment of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
Itaru MatsumuraDepartment of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rare systemic inflammatory disorder 'adult-onset Still's disease (AOSD)' is characterized by recurrent fever, evanescent rash, arthralgia, and leukocytosis with neutrophilia. The Yamaguchi criteria are widely used to diagnose AOSD; these criteria can be used for diagnosis after a wide range of infectious, rheumatic, and neoplastic diseases have been excluded. AOSD generally does not overlap with other rheumatic diseases. We present the rare case of an 80-year-old Japanese woman who presented with arthralgia, fever, and skin rash during treatment for systemic lupus erythematosus (SLE), which was finally diagnosed as an overlap of AOSD. Blood tests revealed leukocytosis with neutrophilia, high C-reactive protein (CRP), and liver dysfunction. Her anti-ds-DNA antibody titer and serum complement titer were at the same level as before and remained stable. We suspected AOSD based on the high serum ferritin level but hesitated to diagnose AOSD because of the patient's SLE history. We measured serum interleukin (IL)-18; it was extremely high at 161,221 pg/mL, which was strongly suggestive of AOSD. We thus diagnosed AOSD complicated during the course of treatment for SLE. The patient's arthralgia and high CRP level persisted after we increased her oral prednisolone dose and added oral methotrexate, but her symptoms eventually improved with the addition of intravenous tocilizumab. We note that the presence of autoantibodies or other rheumatic diseases cannot be absolutely ruled out in the diagnosis of AOSD. Although high serum IL-18 levels are not specific for AOSD, the measurement of serum IL-18 may aid in the diagnosis of AOSD in similar rare cases.

Indexed as

Aged, 80 and overAntibodies, Monoclonal, HumanizedBiomarkersFemaleHumansInterleukin-18Lupus Erythematosus, SystemicMethotrexatePrednisoloneStill's Disease, Adult-OnsetAntibodies, Monoclonal, HumanizedBiomarkersInterleukin-18MethotrexatePrednisolonetocilizumabadult-onset Still’s diseasecase reportoverlaprheumatic diseasessystemic lupus erythematosus

Identifiers

PMID35116046
PMCPMC8803898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.